SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Johanna Stoevesandt, Christine Hosp, Andreas Kerstan, Axel Trautmann, Risk stratification of systemic allergic reactions during Hymenoptera venom immunotherapy buildup phase, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2014, 12, 3
  2. 2
    Alice Köhli-Wiesner, Lisbeth Stahlberger, Christian Bieli, Tamar Stricker, Roger Lauener, Induction of Specific Immunotherapy with Hymenoptera Venoms Using Ultrarush Regimen in Children: Safety and Tolerance, Journal of Allergy, 2012, 2012, 1

    CrossRef

  3. You have free access to this content3
    M. T. Krishna, P. W. Ewan, L. Diwakar, S. R. Durham, A. J. Frew, S. C. Leech, S. M. Nasser, Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines, Clinical & Experimental Allergy, 2011, 41, 9
  4. 4
    Cristoforo Incorvaia, Franco Frati, Ilaria Dell'Albani, Anna Robino, Eleonora Cattaneo, Marina Mauro, Marie David, Rosanna Qualizza, Elide Pastorello, Safety of hymenoptera venom immunotherapy: a systematic review, Expert Opinion on Pharmacotherapy, 2011, 12, 16, 2527

    CrossRef

  5. 5
    Jun Chen, William R. Lariviere, The nociceptive and anti-nociceptive effects of bee venom injection and therapy: A double-edged sword, Progress in Neurobiology, 2010, 92, 2, 151

    CrossRef

  6. 6
    Lucyna Gorska, Marta Chelminska, Krzysztof Kuziemski, Marcin Skrzypski, Marek Niedoszytko, Iwona Damps-Konstanska, Amelia Szymanowska, Alicja Siemińska, Beata Wajda, Adrianna Drozdowska, Marek Jutel, Ewa Jassem, Analysis of Safety, Risk Factors and Pretreatment Methods during Rush Hymenoptera Venom Immunotherapy, International Archives of Allergy and Immunology, 2008, 147, 3, 241

    CrossRef

  7. You have free access to this content7
    G. K. Scadding, S. R. Durham, R. Mirakian, N. S. Jones, S. C. Leech, S. Farooque, D. Ryan, S. M. Walker, A. T. Clark, T. A. Dixon, S. R. A. Jolles, N. Siddique, P. Cullinan, P. H. Howarth, S. M. Nasser, BSACI guidelines for the management of allergic and non-allergic rhinitis, Clinical & Experimental Allergy, 2008, 38, 1
  8. 8
    W. Chen, M. Mempel, W. Schober, H. Behrendt, J. Ring, Gender difference, sex hormones, and immediate type hypersensitivity reactions, Allergy, 2008, 63, 11
  9. 9
    F. Bonifazi, M. Jutel, B. M. Biló, J. Birnbaum, U. Muller, Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice, Allergy, 2005, 60, 12
  10. 10
    F Lavaud, J.F Fontaine, G Deslée, D Sabouraud, F Lebargy, Peut-on arrêter une désensibilisation aux venins d’hyménoptères ?, Revue Française d'Allergologie et d'Immunologie Clinique, 2004, 44, 3, 276

    CrossRef

  11. 11
    J. Birnbaum, M. Ramadour, A. Magnan, D. Vervloet, Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors, Clinical & Experimental Allergy, 2003, 33, 1
  12. 12
    Arnon Goldberg, Ronit Confino-Cohen, Rush venom immunotherapy in patients experiencing recurrent systemic reactions to conventional venom immunotherapy, Annals of Allergy, Asthma & Immunology, 2003, 91, 4, 405

    CrossRef

  13. 13
    J. Wenzel, M. Meissner-Kraemer, R. Bauer, T. Bieber, R. Gerdsen, Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients, Allergy, 2003, 58, 11
  14. 14
    Jean Meaume, Envenimation par les hyménoptères, Revue Française des Laboratoires, 2002, 2002, 342, 27

    CrossRef

  15. 15
    Gunter Sturm, Birger Kränke, Christina Rudolph, Werner Aberer, Rush Hymenoptera venom immunotherapy: A safe and practical protocol for high-risk patients, Journal of Allergy and Clinical Immunology, 2002, 110, 6, 928

    CrossRef

  16. 16
    Arnon Goldberg, Ronit Confino-Cohen, Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious, Journal of Allergy and Clinical Immunology, 2001, 107, 5, 902

    CrossRef

  17. 17
    Dennis K. Ledford, EFFICACY OF IMMUNOTHERAPY, Immunology and Allergy Clinics of North America, 2000, 20, 3, 503

    CrossRef

  18. 18
    Randolf Brehler, Hendrik Wolf, Birgitta Kütting, Jörg Schnitker, Thomas Luger, Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections, Journal of Allergy and Clinical Immunology, 2000, 105, 6, 1231

    CrossRef

  19. 19
    H. Mosbech, U. Müller, On Behalf Of The Study Group*, Side-effects of insect venom immunotherapy:results from an EAACI multicenter study, Allergy, 2000, 55, 11
  20. 20
    F Rancé, M Abbal, F Brémont, G Dutau, Allergie aux venins d'hyménoptères chez l'enfant, Archives de Pédiatrie, 1999, 6, s55

    CrossRef

  21. 21
    D. Vervloet, J. Birnbaum, Venom immunotherapy, Revue Française d'Allergologie et d'Immunologie Clinique, 1998, 38, 7, S243

    CrossRef

  22. 22
    Simon McHugh, Immunological responses to immunotherapy, Clinical & Experimental Allergy, 1996, 26, 10
  23. 23
    Gregory P. Wedin, Daniel E. Keyler, Elisabeth F. Bilden, Poisons of Animal Origin, General, Applied and Systems Toxicology,